SCHEMBL24200303

SCHEMBL24200303

CCOc1ccc(CC(=O)O)c(OC(C)CC)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.44
▸ AKR1C2 P52895 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.41
▸ MAPT P10636 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ TSHR P16473 2/20 0.40
▸ RXRA P19793 1/20 0.40
▸ CAMK2A Q9UQM7 1/20 0.39
▸ SQSTM1 Q13501 1/20 0.38
▸ KEAP1 Q14145 1/20 0.38
▸ NFE2L2 Q16236 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ PPARG P37231 2/20 0.37
▸ PPARD Q03181 2/20 0.37
▸ PPARA Q07869 2/20 0.37
▸ PTGS2 P35354 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24200105 0.77 CXCL8 (0.50) MAPTL3MBTL1CAMK2A
SCHEMBL8086435 0.77 CXCL8 (0.50) MAPTL3MBTL1CAMK2A
SCHEMBL23656671 0.76 ALDH1A1 (0.41) KDM4EHSD17B10MAPTL3MBTL1TSHR
SCHEMBL21437911 0.76 POLB (0.51) AKR1C3AKR1C2KDM4EHSD17B10MAPT
SCHEMBL11070050 0.76 HSD17B10 (0.50) AKR1C3AKR1C2KDM4EHSD17B10MAPT
SCHEMBL23229043 0.76 HSD17B10 (0.62) AKR1C3AKR1C2KDM4EHSD17B10MAPT
SCHEMBL21455738 0.72 TSHR (0.45) AKR1C3AKR1C2KDM4EHSD17B10MAPT
SCHEMBL23656620 0.71 PDE10A (0.44) KDM4EHSD17B10ALDH1A1
SCHEMBL16930126 0.71 THRB (0.51) AKR1C3AKR1C2KDM4EHSD17B10MAPT
SCHEMBL16267829 0.71 KDM4E (0.52) AKR1C3AKR1C2KDM4EHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3939658-A1 SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2022-01-19 — — EP disclosed
Send feedback